UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Selective colonization ability of human fecal microbes in different mouse gut environments

The ISME Journal, 2019-03, Vol.13 (3), p.805-823

2019

Link zum Volltext

Verfügbarkeit prüfen

S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (19), p.5360-5373

2017

Link zum Volltext

Verfügbarkeit prüfen

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

Nature communications, 2023-05, Vol.14 (1), p.2897-2897, Article 2897

2023

Link zum Volltext

Verfügbarkeit prüfen

FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance

Nature cell biology, 2021-11, Vol.23 (11), p.1187

2021

Link zum Volltext

Verfügbarkeit prüfen

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models

Cell reports (Cambridge), 2021-10, Vol.37 (1), p.109788-109788, Article 109788

2021

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment

Scientific reports, 2023-02, Vol.13 (1), p.3051-3051, Article 3051

2023

Link zum Volltext

Verfügbarkeit prüfen

miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma

Nature metabolism, 2019-04, Vol.1 (4), p.460-474

2019

Link zum Volltext

Verfügbarkeit prüfen

The nuclear envelope environment and its cancer connections

Nature reviews. Cancer, 2012-03, Vol.12 (3), p.196

2012

Link zum Volltext

Verfügbarkeit prüfen

Nascent DNA Processing by RecJ Favors Lesion Repair over Translesion Synthesis at Arrested Replication Forks in Escherichia coli

Proceedings of the National Academy of Sciences - PNAS, 2006-06, Vol.103 (24), p.9154-9159

2006

Link zum Volltext

Verfügbarkeit prüfen

DNA Damage-Induced Replication Fork Regression and Processing in Escherichia coli

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5609), p.1064-1067

2003

Link zum Volltext

Verfügbarkeit prüfen

Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2

Nucleus (Austin, Tex.), 2012-07, Vol.3 (4), p.349-358

2012

Link zum Volltext

Verfügbarkeit prüfen

RecO Acts with RecF and RecR to Protect and Maintain Replication Forks Blocked by UV-induced DNA Damage in Escherichia coli

The Journal of biological chemistry, 2004-01, Vol.279 (5), p.3492-3496

2004

Link zum Volltext

Verfügbarkeit prüfen

Correction: Selective colonization ability of human fecal microbes in different mouse gut environments

The ISME Journal, 2020-07, Vol.14 (7), p.1912-1913

2020

Link zum Volltext

Verfügbarkeit prüfen

Expression and function of ABCG2 and XIAP in glioblastomas

Journal of neuro-oncology, 2017-05, Vol.133 (1), p.47-57

2017

Link zum Volltext

Verfügbarkeit prüfen

The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function

Molecular biology of the cell, 2014-01, Vol.25 (1), p.160-168

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition

Cancer biology & therapy, 2019-02, Vol.20 (2), p.169-182

2019

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4864-4874

2014

Link zum Volltext

Verfügbarkeit prüfen

RecBCD and RecJ/RecQ Initiate DNA Degradation on Distinct Substrates in UV-Irradiated Escherichia coli

Radiation research, 2007-10, Vol.168 (4), p.499-506

2007

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and therapeutic implications of hypermutation in gliomas

Nature (London), 2020-04, Vol.580 (7804), p.517-523

2020

Link zum Volltext

Verfügbarkeit prüfen

LGG-48. The influence of different FGFR1 alterations on pediatric low-grade glioma tumor biology and targeted therapy response

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i99-i99

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting Homologous Recombination in Lymphoid Malignancies: Evaluation of Four Small Molecule Inhibitors of RAD51

Blood, 2019-11, Vol.134 (Supplement_1), p.2080-2080

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 347: Targeting the AICDA/RAD51 axis: A novel gain-of-function synthetic lethal therapy for the treatment of AICDA-expressing cancers

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.347-347

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-01-04: FGFR inhibitor mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces therapeutic resistance in triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-01-04

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective colonization ability of human fecal microbes in different mouse gut environments

S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma

FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models

Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment

miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma

The nuclear envelope environment and its cancer connections

Nascent DNA Processing by RecJ Favors Lesion Repair over Translesion Synthesis at Arrested Replication Forks in Escherichia coli

DNA Damage-Induced Replication Fork Regression and Processing in Escherichia coli

VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system

Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2

Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions

RecO Acts with RecF and RecR to Protect and Maintain Replication Forks Blocked by UV-induced DNA Damage in Escherichia coli

Correction: Selective colonization ability of human fecal microbes in different mouse gut environments

Expression and function of ABCG2 and XIAP in glioblastomas

The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function

Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition

Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity

RecBCD and RecJ/RecQ Initiate DNA Degradation on Distinct Substrates in UV-Irradiated Escherichia coli

Mechanisms and therapeutic implications of hypermutation in gliomas

LGG-48. The influence of different FGFR1 alterations on pediatric low-grade glioma tumor biology and targeted therapy response

Targeting Homologous Recombination in Lymphoid Malignancies: Evaluation of Four Small Molecule Inhibitors of RAD51

Abstract 347: Targeting the AICDA/RAD51 axis: A novel gain-of-function synthetic lethal therapy for the treatment of AICDA-expressing cancers

Abstract P4-01-04: FGFR inhibitor mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces therapeutic resistance in triple negative breast cancer

Suchergebnisse filtern